These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20167419)

  • 1. Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods.
    Königsberg R; Gneist M; Jahn-Kuch D; Pfeiler G; Hager G; Hudec M; Dittrich C; Zeillinger R
    Cancer Lett; 2010 Jul; 293(1):117-23. PubMed ID: 20167419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
    Cohen SJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse M; Mitchell E; Miller MC; Doyle GV; Tissing H; Terstappen LW; Meropol NJ
    J Clin Oncol; 2008 Jul; 26(19):3213-21. PubMed ID: 18591556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
    Cohen SJ; Alpaugh RK; Gross S; O'Hara SM; Smirnov DA; Terstappen LW; Allard WJ; Bilbee M; Cheng JD; Hoffman JP; Lewis NL; Pellegrino A; Rogatko A; Sigurdson E; Wang H; Watson JC; Weiner LM; Meropol NJ
    Clin Colorectal Cancer; 2006 Jul; 6(2):125-32. PubMed ID: 16945168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
    Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
    Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination-free flow cytometry.
    Takao M; Takeda K
    Cytometry A; 2011 Feb; 79(2):107-17. PubMed ID: 21246706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells in solid tumor in metastatic and localized stages.
    Maestro LM; Sastre J; Rafael SB; Veganzones SB; Vidaurreta M; Martín M; Olivier C; DE La Orden VB; Garcia-Saenz JA; Alfonso R; Arroyo M; Diaz-Rubio E
    Anticancer Res; 2009 Nov; 29(11):4839-43. PubMed ID: 20032444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients.
    Gervasoni A; Sandri MT; Nascimbeni R; Zorzino L; Cassatella MC; Baglioni L; Panigara S; Gervasi M; Di Lorenzo D; Parolini O
    Oncol Rep; 2011 Jun; 25(6):1669-703. PubMed ID: 21455578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.
    Hiraiwa K; Takeuchi H; Hasegawa H; Saikawa Y; Suda K; Ando T; Kumagai K; Irino T; Yoshikawa T; Matsuda S; Kitajima M; Kitagawa Y
    Ann Surg Oncol; 2008 Nov; 15(11):3092-100. PubMed ID: 18766405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
    Alunni-Fabbroni M; Sandri MT
    Methods; 2010 Apr; 50(4):289-97. PubMed ID: 20116432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation.
    Resel Folkersma L; Olivier Gómez C; San José Manso L; Veganzones de Castro S; Galante Romo I; Vidaurreta Lázaro M; de la Orden GV; Arroyo Fernández M; Díaz Rubio E; Silmi Moyano A; Maestro de Las Casas MA
    Arch Esp Urol; 2010; 63(1):23-31. PubMed ID: 20157216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
    Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
    Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS.
    Martin VM; Siewert C; Scharl A; Harms T; Heinze R; Ohl S; Radbruch A; Miltenyi S; Schmitz J
    Exp Hematol; 1998 Mar; 26(3):252-64. PubMed ID: 9502622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
    Dawood S; Broglio K; Valero V; Reuben J; Handy B; Islam R; Jackson S; Hortobagyi GN; Fritsche H; Cristofanilli M
    Cancer; 2008 Nov; 113(9):2422-30. PubMed ID: 18785255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer.
    Okegawa T; Hayashi K; Hara H; Nutahara K; Higashihara E
    Int J Urol; 2010 Mar; 17(3):254-8. PubMed ID: 20148989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study.
    Blümke K; Bilkenroth U; Schmidt U; Melchior A; Füssel S; Bartel F; Heynemann H; Fornara P; Taubert H; Wirth MP; Meye A
    Oncol Rep; 2005 Oct; 14(4):895-9. PubMed ID: 16142348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global gene expression profiling of circulating tumor cells.
    Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique localization of circulating tumor cells in patients with hepatic metastases.
    Jiao LR; Apostolopoulos C; Jacob J; Szydlo R; Johnson N; Tsim N; Habib NA; Coombes RC; Stebbing J
    J Clin Oncol; 2009 Dec; 27(36):6160-5. PubMed ID: 19884529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.